Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Dec;40(6):914–921. doi: 10.1038/bjc.1979.285

The carcinogenicity of 15,16-dihydro-11-methyl-cyclopenta[a]phenanthren-17-one.

M M Coombs, T S Bhatt, S Young
PMCID: PMC2010134  PMID: 526432

Abstract

Direct comparison of skin-tumour induction by 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one (I) and by benzo[a]pyrene on mouse skin, both by repeated application or by initiation with a single dose followed by promotion with croton oil, demonstrated that these two carcinogens have similar potency. After repeated application of (I) the mean latent period for skin-tumour induction was linearly related to the logarithm of the dose over a 10-fold dose range. Under these conditions, application of the aryl-hydrocarbon-hydroxylase inhibitor 7,8-benzoflavone together with (I) inhibited tumour induction by about 40%. By contrast, in the 2-stage experiment, little effect on tumour incidence or latent period was observed when this inhibitor was applied with the single initiating dose of (I). Co-administration of the epoxide-hydratase inhibitor 1,1,1-trichloropropene oxide caused enhancement by shortening the latent period. After s.c. injection of (I) into mice, a similar number of tumours was induced on skin remote from the site of injection by promotion with corton oil begun either one week or 6 months after initiation. Gastric instillation of (I) into female rats induced mammary adenocarcinomas.

Full text

PDF
914

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bürki K., Wheeler J. E., Akamatsu Y., Scribner J. E., Candelas G., Bresnick E. Early differential effects of 3-methylcholanthrene and its "K-region" epoxide on mouse skin. Possible implication in the two-stage mechanism of tumorigenesis. J Natl Cancer Inst. 1974 Oct;53(4):967–976. doi: 10.1093/jnci/53.4.967. [DOI] [PubMed] [Google Scholar]
  2. Coombs M. M., Bhatt T. S., Croft C. J. Correlation between carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes. Cancer Res. 1973 Apr;33(4):832–837. [PubMed] [Google Scholar]
  3. Coombs M. M., Bhatt T. S. Lack of initiating activity in mutagens which are not carcinogenic. Br J Cancer. 1978 Jul;38(1):148–150. doi: 10.1038/bjc.1978.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coombs M. M., Bhatt T. S. Potentially carcinogenic cyclopenta(a)phenanthrenes. VI. 1,2,3,4-Tetrahydro-17-ketones. J Chem Soc Perkin 1. 1973;12:1251–1254. doi: 10.1039/p19730001251. [DOI] [PubMed] [Google Scholar]
  5. Coombs M. M., Bhatt T. S., Vose C. W. The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor. Cancer Res. 1975 Feb;35(2):305–309. [PubMed] [Google Scholar]
  6. Coombs M. M., Croft C. J. Carcinogenic cyclopenta[a]phenanthrenes. Prog Exp Tumor Res. 1969;11:69–85. doi: 10.1159/000391389. [DOI] [PubMed] [Google Scholar]
  7. Coombs M. M., Kissonerghis A. M., Allen J. A., Vose C. W. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Cancer Res. 1979 Oct;39(10):4160–4165. [PubMed] [Google Scholar]
  8. Coombs M. M. Potentially carcinogenic cyclopenta[a]phenanthrenes (1,2-cyclopentenophenanthrenes). I. A new synthesis of 15,16-dihydro-17-oxocyclopenta[a]phenanthrene and the phenanthrene analogue of 18-noroestrone methyl ether. J Chem Soc Perkin 1. 1966;10:955–962. doi: 10.1039/j39660000955. [DOI] [PubMed] [Google Scholar]
  9. Grundin R., Jakobsson S., Cinti D. L. Induction of microsomal aryl hydrocarbon (3,4-benzo(alpha)pyrene) hydroxylase and cytochrome P-450K in rat kidney cortex. I. Characteristics of the hydroxylase system. Arch Biochem Biophys. 1973 Oct;158(2):544–555. doi: 10.1016/0003-9861(73)90547-x. [DOI] [PubMed] [Google Scholar]
  10. Hill D. L., Shih T. W. Inhibition of benzo(alpha)pyrene metabolism catalyzed by mouse and hamster lung microsomes. Cancer Res. 1975 Oct;35(10):2717–2723. [PubMed] [Google Scholar]
  11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  12. SHAY H., AEGERTER E. A. Development of adenocarcinoma of the breast in the Wistar rat following the gastric instillation of methylcholanthrene. J Natl Cancer Inst. 1949 Oct;10(2):255–266. [PubMed] [Google Scholar]
  13. Selkirk J. K., Croy R. G., Roller P. P., Gelboin H. V. High-pressure liquid chromatographic analysis of benzo(alpha)pyrene metabolism and covalent binding and the mechanism of action of 7,8-benzoflavone and 1,2-epoxy-3,3,3-trichloropropane. Cancer Res. 1974 Dec;34(12):3474–3480. [PubMed] [Google Scholar]
  14. Wood A. W., Wislocki P. G., Chang R. L., Levin W., Lu A. Y., Yagi J., Hernandez O., Herina D. M., Conney A. H. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res. 1976 Sep;36(9 PT1):3358–3366. [PubMed] [Google Scholar]
  15. YANG N. C., CASTRO A. J., LEWIS M., WONG T. W. Polynuclear aromatic hydrocarbons, steroids and carcinogenesis. Science. 1961 Aug 11;134(3476):386–387. doi: 10.1126/science.134.3476.386. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES